You think that 12 wks dosing is long enough to see impact ?
My expectation was it might take a bit longer to fully show the drug effect, so that makes me lower probability a bit.
Also I was expecting a longer follow-up, but maybe they will do that if they see a good initial effect by offering an extension study.
Lastly if it is just 120 subjects and a 3 month trial in NASH why are they projecting 18 months to completion. NASH is no orphan disease and unless they are deliberately going at old Corcept slow speed, they should be able to wrap up the trial in less than a year.